About

BioNap Consulting, Inc. is an investor intelligence and strategic advisory firm that produces high-quality equity research on companies in the pharmaceutical, biotechnology, and medical device sector. We work directly with both investors and biopharma companies in an effort to achieve the common goal of maximizing investment in the healthcare sector.

BioNap Consulting provides equity research, due diligence, valuation analysis, market research, and strategic advice on M&A or product in/out-licensing opportunities. We are experienced advisors on the investor relations and business development side. We understand social media and how to both educate and engage with investors to maximize the investor relations effort.

BioNap sponsored research articles are written to educate and inform investors. We pride ourselves on the fact that when we publish industry statistics, clinical data, epidemiology, etiology, or physiology background information, our readers can trust our sources and know we are providing fair and balanced work. Our facts are clearly sourced to medical journals, professional associations, or well-respected industry research. And when we state opinion, we do so by using phrases such as "I believe" or "I think" so that investors can clearly distinguish between fact and opinion in our work.